Cancer Genomics Epidemiology: Resource Archive

Archived Surveillance Reports

Cancer Genomics in Michigan: Surveillance Report, 2012 (September 2012)

1. BRCA 1/2 Surveillance in Michigan, 2008-2012
2. Gene Expression Profiling (GEP) for Breast Cancer Recurrence Risk Prediction, Surveillance in Michigan, 2008-2012

Utilization of Michigan Cancer Genetics Services, 2007-2011: Findings from the BRCA Clinical Genetic Counseling Database (June 2012)

1. Introduction
2. Patient Demographics
3. Referring Provider
4. Age and Personal History
5. Number of BRCA Tests Over Time
6. Patient Services Over Time
7. Test Results by Personal and Family History
8. Characteristics of Patients Tested
    

Archived Poster Presentations

• Fear of Cancer Recurrence, Perceived Risk, Self-Efficacy and Barriers to Screening in Young Breast Cancer Survivors  (June 2014)
• Innovative Utilization of a State Cancer Registry to Contact Young Breast Cancer Survivors and their High-Risk Female Relatives to Increase Breast Cancer Screening  (June 2014)
• Mutation Rates and Reasons for Declining BRCA Genetic Testing Among Women with Breast or Ovarian Cancer  (June 2014)
• Timing of BRCA Genetic Testing and Extent of Breast Cancer Surgery in Women with Deleterious Mutations  (June 2014)
• Family Notification and Cascade Screening After BRCA Genetic Testing  (April 2014)
• Examining Statewide Patterns in Collection of Family History Variables for the Michigan Cancer Surveillance Program  (April 2013)
• Growth of BRCA1/2 Genetic Testing in Michigan, 2008-2011  (April 2013)
• Reasons for Declining BRCA Testing After Genetic Counseling  (April 2012)
• Utilization of Cancer Genetic Services by Young Female Breast Cancer Survivors  (April 2012)
• Using State Cancer Registries to Evaluate Potentially Hereditary Cancers  (December 2010)
   

Return to Cancer Genomics Epidemiology home page
Last updated: 05/03/2022